Phage therapy: a revolutionary shift in the management of bacterial infections, pioneering new horizons in clinical practice, and reimagining the arsenal against microbial pathogens
- PMID: 37928478
- PMCID: PMC10620811
- DOI: 10.3389/fmed.2023.1209782
Phage therapy: a revolutionary shift in the management of bacterial infections, pioneering new horizons in clinical practice, and reimagining the arsenal against microbial pathogens
Abstract
The recent approval of experimental phage therapies by the FDA and other regulatory bodies with expanded access in cases in the United States and other nations caught the attention of the media and the general public, generating enthusiasm for phage therapy. It started to alter the situation so that more medical professionals are willing to use phage therapies with conventional antibiotics. However, more study is required to fully comprehend phage therapy's potential advantages and restrictions, which is still a relatively new field in medicine. It shows promise, nevertheless, as a secure and prosperous substitute for antibiotics when treating bacterial illnesses in animals and humans. Because of their uniqueness, phage disinfection is excellent for ready-to-eat (RTE) foods like milk, vegetables, and meat products. The traditional farm-to-fork method can be used throughout the food chain to employ bacteriophages to prevent food infections at all production stages. Phage therapy improves clinical outcomes in animal models and lowers bacterial burdens in numerous preclinical investigations. The potential of phage resistance and the need to make sure that enough phages are delivered to the infection site are obstacles to employing phages in vivo. However, according to preclinical studies, phages appear to be a promising alternative to antibiotics for treating bacterial infections in vivo. Phage therapy used with compassion (a profound understanding of and empathy for another's suffering) has recently grown with many case reports of supposedly treated patients and clinical trials. This review summarizes the knowledge on the uses of phages in various fields, such as the food industry, preclinical research, and clinical settings. It also includes a list of FDA-approved bacteriophage-based products, commercial phage products, and a global list of companies that use phages for therapeutic purposes.
Keywords: bacteriophage; immune response; preclinical AND clinical trials; treatment challenges; veterinary medicine.
Copyright © 2023 Karn, Gangwar, Kumar, Bhartiya and Nath.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.Infect Dis Rep. 2024 Nov 28;16(6):1127-1181. doi: 10.3390/idr16060092. Infect Dis Rep. 2024. PMID: 39728014 Free PMC article. Review.
-
Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.Expert Opin Drug Deliv. 2017 Aug;14(8):959-972. doi: 10.1080/17425247.2017.1252329. Epub 2016 Nov 10. Expert Opin Drug Deliv. 2017. PMID: 27776446 Review.
-
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?Clin Ther. 2020 Sep;42(9):1659-1680. doi: 10.1016/j.clinthera.2020.07.014. Epub 2020 Aug 31. Clin Ther. 2020. PMID: 32883528 Review.
-
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.Adv Colloid Interface Sci. 2017 Nov;249:100-133. doi: 10.1016/j.cis.2017.05.014. Epub 2017 May 14. Adv Colloid Interface Sci. 2017. PMID: 28688779 Review.
-
Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.J Antimicrob Chemother. 2014 Sep;69(9):2326-36. doi: 10.1093/jac/dku173. Epub 2014 May 28. J Antimicrob Chemother. 2014. PMID: 24872344 Review.
Cited by
-
Metagenomics as a Transformative Tool for Antibiotic Resistance Surveillance: Highlighting the Impact of Mobile Genetic Elements with a Focus on the Complex Role of Phages.Antibiotics (Basel). 2025 Mar 12;14(3):296. doi: 10.3390/antibiotics14030296. Antibiotics (Basel). 2025. PMID: 40149106 Free PMC article. Review.
-
Phage therapy: A novel approach against multidrug-resistant pathogens.3 Biotech. 2024 Oct;14(10):256. doi: 10.1007/s13205-024-04101-8. Epub 2024 Sep 30. 3 Biotech. 2024. PMID: 39355200 Free PMC article. Review.
-
Engineered bacteriophages: A panacea against pathogenic and drug resistant bacteria.Heliyon. 2024 Jul 9;10(14):e34333. doi: 10.1016/j.heliyon.2024.e34333. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39100447 Free PMC article. Review.
-
Relative fitness of wild-type and phage-resistant pyomelanogenic P. aeruginosa and effects of combinatorial therapy on resistant formation.Heliyon. 2024 Nov 2;10(21):e40076. doi: 10.1016/j.heliyon.2024.e40076. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39559211 Free PMC article.
-
In vitro characterization and genome sequencing of two novel lytic phages against Salmonella Infantis isolated from poultry feces.Front Microbiol. 2024 Dec 5;15:1479700. doi: 10.3389/fmicb.2024.1479700. eCollection 2024. Front Microbiol. 2024. PMID: 39703709 Free PMC article.
References
-
- O’Neill J. Antimicrobial resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. (2014).
-
- Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. . Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. (2018) 18:318–27. doi: 10.1016/S1473-3099(17)30753-3, PMID: - DOI - PubMed
-
- Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, et al. . Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis. (2019) 19:35–45. doi: 10.1016/S1473-3099(18)30482-1, PMID: - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources